Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai MicuRx Pharmaceutical Co's Days Payable or its related term are showing as below:
SHSE:688373'
s Days Payable Range Over the Past 10 Years
Min: 754.68 Med: 1286.07 Max: 93805
Current: 1218.85
During the past 8 years, Shanghai MicuRx Pharmaceutical Co's highest Days Payable was 93805.00. The lowest was 754.68. And the median was 1286.07.
SHSE:688373's Days Payable is ranked better than 97.09% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:688373: 1218.85
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicuRx Pharmaceutical Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai MicuRx Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai MicuRx Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai MicuRx Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shanghai MicuRx Pharmaceutical Co's Days Payable falls into.
Shanghai MicuRx Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicuRx Pharmaceutical Co (SHSE:688373) has a Days Payable of 1,158.29 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai MicuRx Pharmaceutical Co and its competitors. This is 10% below median its historical median of 1,286.07. Over the past decade, Shanghai MicuRx Pharmaceutical Co's Days Payable has ranged from 754.68 to 93,805.00. According to the industry distribution chart, Shanghai MicuRx Pharmaceutical Co ranks #27 out of 927 companies in the Drug Manufacturers industry, placing it in the top 2.9%.
Is Shanghai MicuRx Pharmaceutical Co's Days Payable too high?
Shanghai MicuRx Pharmaceutical Co's current Days Payable of 1,158.29 is 10% below median its 10-year median of 1,286.07. Over the past 10 years, this metric has ranged from a low of 754.68 to a high of 93,805.00. The Drug Manufacturers industry median Days Payable is 90.38. Shanghai MicuRx Pharmaceutical Co's value of 1,158.29 is 1181.6% above this industry median. Based on the distribution chart, Shanghai MicuRx Pharmaceutical Co ranks #27 out of 927 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai MicuRx Pharmaceutical Co has a GF Score™ of 30/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicuRx Pharmaceutical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai MicuRx Pharmaceutical Co ranks #27 out of 927 companies for Days Payable. This places Shanghai MicuRx Pharmaceutical Co in the top 3% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.38. Shanghai MicuRx Pharmaceutical Co's value of 1,158.29 is 1181.6% above this benchmark. Historically, Shanghai MicuRx Pharmaceutical Co's own Days Payable has ranged from 754.68 to 93,805.00 over the past decade. While the company's 10-year median is 1,286.07 vs. the industry median of 90.38, Shanghai MicuRx Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai MicuRx Pharmaceutical Co's current Days Payable of 1,158.29 is 1181.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai MicuRx Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai MicuRx Pharmaceutical Co's current Days Payable is 1,158.29, which is 10% below median its own 10-year median of 1,286.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicuRx Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicuRx Pharmaceutical Co (SHSE:688373) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.58, compared to a current price of ¥4.92 — trading 35.1% below its estimated fair value. The current Days Payable is 1,158.29, which is 10% below median its 10-year median of 1,286.07 and 1181.6% above the Drug Manufacturers industry median of 90.38. Shanghai MicuRx Pharmaceutical Co's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai MicuRx Pharmaceutical Co (SHSE:688373), the current Days Payable is 1,158.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai MicuRx Pharmaceutical Co (SHSE:688373) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai MicuRx Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥4.92 is trading 35.1% below its estimated GF Value™ of ¥7.58.
GuruFocus considers Shanghai MicuRx Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for SHSE:688373:
Days Payable: 1,158.29 (10% below median its 10-year median of 1,286.07)
GF Value™: ¥7.58 vs. price of ¥4.92 (35.1% below fair value)
Industry Position: 1181.6% above the Drug Manufacturers median (#27 of 927)
No single metric tells the full story. See the SHSE:688373 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai MicuRx Pharmaceutical Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688373 has been successfully added to your 
